Evidence map›Paper›PMID 34341013›Full record

ArticleCancer prevention research (Philadelphia, Pa.)2021

Immune Responses Vary in Preinvasive Colorectal Lesions by Tumor Location and Histology.

Kristin Wallace, Georges J El Nahas, Christine Bookhout, Jessica E Thaxton, David N Lewin, Nana Nikolaishvili-Feinberg, Stephanie M Cohen, J Grant Brazeal, Elizabeth G Hill, Jennifer D Wu and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer prevention research (Philadelphia, Pa.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Differences in T-cell Densities and Neighborhood Patterns in Human Colorectal Adenomas and Sessile Serrated Lesions.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Kristin WallaceHollings Cancer Center, Medical University of South Carolina (MUSC), Charleston, South Carolina. wallack@musc.edu.
Georges J El NahasHollings Cancer Center, Medical University of South Carolina (MUSC), Charleston, South Carolina.
Christine BookhoutDepartment of Pathology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.ORCID 0000-0002-1709-685X
Jessica E ThaxtonHollings Cancer Center, Medical University of South Carolina (MUSC), Charleston, South Carolina.
David N LewinDepartment of Pathology and Laboratory Medicine, MUSC, Charleston, South Carolina.
Nana Nikolaishvili-FeinbergLineberger Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
Stephanie M CohenLineberger Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina.ORCID 0000-0003-4784-5548
J Grant BrazealDepartment of Public Health Sciences, MUSC, Charleston, South Carolina.ORCID 0000-0002-8416-1092
Elizabeth G HillHollings Cancer Center, Medical University of South Carolina (MUSC), Charleston, South Carolina.
Jennifer D WuFeinberg School of Medicine, Northwestern University, Chicago, Illinois.
John A BaronDepartment of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina.ORCID 0000-0003-3461-1056
Alexander V AlekseyenkoHollings Cancer Center, Medical University of South Carolina (MUSC), Charleston, South Carolina.
Medical University of South Carolina · USUniversity of North Carolina at Chapel Hill · USNorthwestern University · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI STACIE B DUSETZINA · 1995 to 2026
$172.8M
Translational Science Laboratory Shared ResourceP30CA138313 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Jian Ouyang · 2009 to 2026
$42.7M
South Carolina Clinical & Translational Research Institute (SCTR)UL1TR001450 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T., FLUME, PATRICK A · 2015 to 2024
$41.1M
South Carolina Clinical & Translational Research Institute (SCTR)UL1TR000062 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T. · 2012 to 2014
$9.4M
Proteomics CoreP30DK123704 · NIDDK · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI DON C. ROCKEY · 2020 to 2026
$8.8M
South Carolina Cancer Disparities Research Center (SC CaDRe)U54CA210963 · NCI · SOUTH CAROLINA STATE UNIVERSITY · PI WHITAKER, WILLIAM H. · 2017 to 2023
$6.1M
The immune contexture of colorectal adenomas and serrated polypsR01CA226086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WALLACE, KRISTIN · 2019 to 2023
$3.1M
NKG2D superagonist co-stimulation to enhance adaptive immunotherapy of cancerR01CA208246 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI WU, JENNIFER D · 2016 to 2020
$1.8M
Distance-based Panomic Analytics for Microbiome DataR01LM012517 · NLM · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI ALEKSEYENKO, ALEXANDER V · 2018 to 2021
$1.3M
NCATS NIH HHS UL1 TR000062NCATS NIH HHS UL1 TR001450NCI NIH HHS P30 CA068485NCI NIH HHS P30 CA138313NCI NIH HHS R01 CA208246NCI NIH HHS R01 CA226086NCI NIH HHS U54 CA210963NLM NIH HHS R01 LM012517
6 · The paper itself

Abstract

Immune responses vary in colorectal cancers, which strongly influence prognosis. However, little is known about the variance in immune response within preinvasive lesions. The study aims to investigate how the immune contexture differs by clinicopathologic features (location, histology, dysplasia) associated with progression and recurrence in early carcinogenesis. We performed a cross-sectional study using preinvasive lesions from the surgical pathology laboratory at the Medical University of South Carolina. We stained the tissues with immunofluorescence antibodies, then scanned and analyzed expression using automated image analysis software. We stained CD117 as a marker of mast cells, CD4/RORC to indicate Th17 cells, MICA/B as a marker of NK-cell ligands, and also used antibodies directed against cytokines IL6, IL17A, and IFNγ. We used negative binomial regression analysis to compare analyte density counts by location, histology, degree of dysplasia adjusted for age, sex, race, and batch. All immune markers studied (except IL17a) had significantly higher density counts in the proximal colon than distal colon and rectum. Increases in villous histology were associated with significant decreases in immune responses for IL6, IL17a, NK ligand, and mast cells. No differences were observed in lesions with low- and high-grade dysplasia, except in mast cells. The lesions of the proximal colon were rich in immune infiltrate, paralleling the responses observed in normal mucosa and invasive disease. The diminishing immune response with increasing villous histology suggests an immunologically suppressive tumor environment. Our findings highlight the heterogeneity of the immune responses in preinvasive lesions, which may have implications for prevention strategies. PREVENTION RELEVANCE: Our study is focused on immune infiltrate expression in preinvasive colorectal lesions; our results suggest important differences by clinicopathologic features that have implications for immune prevention research.

Indexed as

AdenomaAgedBiomarkers, TumorColonColorectal NeoplasmsCross-Sectional StudiesFemaleHumansImmunityLymphocytes, Tumor-InfiltratingMaleMiddle AgedNeoplasm InvasivenessNeoplasm StagingPrognosisTumor MicroenvironmentBiomarkers, Tumor

Identifiers

PMID34341013
PMCPMC8811707
OpenAlexW3192121516

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.